Good Morning Market Enthusiast,
 

We’ve been on a roll, and our latest focus is on 22nd Century Group, Inc. (NASDAQ: XXII)—a company that’s quietly making a significant impact. This innovative player is set to disrupt its almost trillion dollar industry with a breakthrough that could reshape the market. 
 

Why now?
 

In addition to being at the forefront of nicotine harm reduction, 22nd Century Group has recently strengthened its financial foundation. Following a key announcement about improving its balance sheet, raising over $11.6 million, and reducing debt, the company is positioned for even stronger growth ahead. (11)
 

At the core of their offering is VLN®—the first and only FDA-authorized cigarette with 95% less nicotine. VLN® provides smokers with a true alternative while supporting them in reducing nicotine consumption, tapping into the growing demand for healthier options.
 

With a stronger financial standing and a one-of-a-kind product, 22nd Century Group is ready to make a lasting impact. 

Now is the time to take notice!
 

Analysts Are Excited

Analysts have been issuing strong ratings for 22nd Century Group over the past year, highlighting its promising growth potential. In addition, recent technical analysis reveals a strong upward trend, indicating positive momentum and confidence. (1)(3)(4)

(3)

Why This Matters:

🏆 Exclusive Regulatory Status: VLN® cigarettes are the only combustible tobacco product authorized by the FDA as a Modified Risk Tobacco Product. This unique status marks a significant leap forward in consumer health. (5)(6)(7)

🌍 Expansive Market Footprint: Currently available in over 5,100 stores across 26 states, 22nd Century Group has plans to grow significantly into a vast market of over 274,000 Tobacco retail locations nationwide. (5)(6)(7)

⚙️ Strong Production & Growth Prospects: Our contract manufacturing operations are expanding, and new agreements have bolstered our production volumes. With a focus on operational efficiency, the company is targeting profitability by Q1 2025. (5)(6)(7)
 

Key Recent Developments:

🌱 Expansion into New Tobacco Products: Production of new filtered cigars and increased export business is set to fully leverage our manufacturing capacity, significantly enhancing revenues. (5)(6)(7)

🔬 R&D and Intellectual Property Strength: Our collaboration with North Carolina State University continues to bolster our leadership in nicotine harm reduction, positioning us for long-term success.  (5)(6)(7)

⭐ Path to Profitability: With growing revenue streams and enhanced cost efficiency, we’re on a clear path towards positive cash flows starting early next year. (5)(6)(7)
 

A Unique Value Proposition:

🔍 FDA Recognition: VLN® is the only combustible cigarette to be authorized by the FDA as a product that “Helps You Smoke Less®”. This recognition provides a powerful competitive edge and positions the company as a leader in reducing nicotine-related harm. (5)(6)(7)

🛠️ Contract Manufacturing Capabilities: Our production facility in Mocksville, North Carolina, is not only producing VLN® but is also capitalizing on the chance to contract manufacture for other brands. Recent expansions into filtered cigars and international cigarette exports are expected to further strengthen revenue streams, providing a substantial, consistent foundation for future growth. (5)(6)(7)

📊 Positive Financial Momentum: The recent earnings report showed strong trends in profitability, driven by a shift in product mix, cost control, and increased manufacturing volumes. With significant reductions in operating expenses and enhancements to the company’s balance sheet, 22nd Century is well-positioned to achieve its goal of profitability by Q1 2025. (5)(6)(7)
 

What's Ahead:
 

With its disruptive approach, 22nd Century Group, Inc. (NASDAQ: XXII) is positioning itself as the go-to choice for adult smokers who want control over their nicotine consumption. The ongoing expansion into new states, the introduction of flanker brands, and a clear commitment to profitability all paint a compelling picture of growth potential.
 

Analysts are optimistic, recent technical analysis shows strength, and the company is expanding into new segments—all signs of a promising trajectory.

(4)

22nd Century Group, Inc. (NASDAQ: XXII) isn’t just participating in the tobacco industry—it’s leading a movement toward harm reduction and giving adult smokers more choices. This is a game-changing chance to get behind a company with innovative technology, FDA recognition, and a robust growth strategy.

To your success,

Max Masters

Co-founder, Market Tips Newsletter

Sources:
1. https://finance.yahoo.com/quote/XXII/
2. https://finance.yahoo.com/quote/XXII/history/
3. https://bit.ly/3NdhMOq 
4. https://bit.ly/4dAdOdj
5. https://bit.ly/4dFlTxw
6. https://1347858.ir365connect.com/   
7. https://bit.ly/3zTu4ID
8. https://bit.ly/4ewc0Ub
9. https://bit.ly/3TZfLt16
10. https://bit.ly/3zSyMq7

11. https://yhoo.it/4eC34wo

Data is provided from third-party sources and Market Tips is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized fin.ancial advice, are not finan.cial advisors, and our opinions are not suitable for all in.vest.ors. Please review our full disc.laim.er here. 

Pursuant to an agreement between Momentum Media LLC and Shore Thing Media LLC, Momentum Media LLC has been hired for a period beginning on 10/07/2024 and ending on 10/08/2024 to publicly disseminate information about (XXII:US) via digital communications. To date we have been paid twenty five thousand dollars USD. We own zero shares of (XXII:US).